Ann: Stable Cell Line for Production of PAT-DX3 Established, page-51

Patrys is unique in the Biotech space where the antibodies penetrate the cell nucleus rather than have to attach to a cell receptor that may be expressed on the cancer cell surface. Its why it has attracted the smart money of Mason Stevens , Macquarie Bank and Kerry Stokes, who have been shareholders for years and paid on average much more than the current 2.5c . Another top 20 multi year holder Dr Dax took up his allocation at the recent 3.5c rights issue. When ever I email him he isn't perturbed by the daily goings on or the share price. His average is above 2.5c and has been holding for as long as I have been into PAB. Those buying now are very fortunate imo.